David Loesch

3.7k citations
38 papers · 2.7k · 1 hit paper · h-index 16

Impact in

  • Oncology top 1%
    • Cancer Treatment and Pharmacology
    • HER2/EGFR in Cancer Research
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • Cancer Genomics and Diagnostics
    • Breast Cancer Treatment Studies

Papers in

    • Cancer Treatment and Pharmacology 12
    • HER2/EGFR in Cancer Research 6
    • Lung Cancer Research Studies 3
    • Lung Cancer Diagnosis and Treatment 5
    • Lung Cancer Treatments and Mutations 5
    • Advanced Breast Cancer Therapies 2

David Loesch

38 papers receiving 2.6k citations

David Loesch's Hit Papers

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study 2011 · 817 citations
8170+5+10Years since publication250500750

Peers

David Loesch
Comparison fields: 5 of 96
  • Oncology 1.4k
  • Cancer Research 562
  • Pulmonary and Respiratory Medicine 734
  • Clinical Biochemistry 80
  • Infectious Diseases 180
Replace Paul H. Gumerlock with:
Paul H. Gumerlock United States
Geoffrey Nichol United States
S. M. Steinberg United States
Ingo Schmidt‐Wolf Germany
Sherry Heldens United States
Pablo J. Cagnoni United States
Heinz Sill Austria
Giuseppe Colucci Italy
Jozef Šufliarský Slovakia
Patricia Bernardo United States
David Loesch relative to Paul H. Gumerlock United States Paul H. Gumerlock's profile →
Citations per field
00.5×3.2×
Paul H. Gumerlock · 1×
Citations per year

Countries citing papers authored by David Loesch

Since Specialization
Citations

This map shows the geographic impact of David Loesch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Loesch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Loesch more than expected).

Fields of papers citing papers by David Loesch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Loesch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Loesch. The network helps show where David Loesch may publish in the future.

Co-authors

The 25 scholars most cited alongside David Loesch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Loesch Line = papers co-authored together David Loesch links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
Hit paper breakdown →
2011817
2 2010444
3 2006343
4 2008303
5
An Outbreak of Infections Caused by Strains of Staphylococcus aureus Resistant to Methicillin and Aminoglycosides.
1979162
6 2011130
7 1999109
8 201458
9 200247
10 201144
11 200435
12 200428
13 200824
14 201524
15 200821
16 201018
17 200814
18 201012
19 200412
20 200711

About David Loesch

David Loesch is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Pharmacology, having authored 38 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (12 papers), HER2/EGFR in Cancer Research (6 papers), Cancer Genomics and Diagnostics (5 papers), Breast Cancer Treatment Studies (5 papers), Lung Cancer Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Research Studies (3 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Oncology (1.4k citations), Cancer Research (562 citations), Pulmonary and Respiratory Medicine (734 citations), Clinical Biochemistry (80 citations) and Infectious Diseases (180 citations). David Loesch has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include J. Wanders, Lina Asmar, Joyce O’Shaughnessy, Joanne L. Blum, Véronique Dièras, Philippe Bougnoux, Linda T. Vahdat, P. Chollet, Seth Seegobin and Javier Cortés. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Clinical Cancer Research, Clinical Breast Cancer and Clinical Genitourinary Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact